Overview

Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Phase I Study of Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.
Phase:
Phase 1
Details
Lead Sponsor:
Leslie Andritsos
Collaborator:
Celgene Corporation
Treatments:
Lenalidomide
Thalidomide